Literature DB >> 6934536

Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety.

M Bennett, K Schmid.   

Abstract

Human plasma alpha 1-acid glycoprotein (orosomucoid) and derivatives of this protein produced by sequential enzymatic cleavage of the glycosidic residue (sialic acid, galactose, N-acetylglucosamine, mannose) were tested for the ability suppress a number of immune functions of mouse spleen cells in vitro at physiological concentrations. alpha 1-Acid glycoprotein and especially the agalacto/asialo derivative suppressed (i) the mitogenic responses to concanavalin A, lipopolysaccharide, and alloantigens, (ii) antibody responses to sheep erythrocytes, and (iii) induction of cell-mediated lympholysis against allogeneic target cells. The native protein and its derivative did not inhibit the proliferation of EL-4 lymphoma cells and did not suppress the lysis of YAC-1 lymphoma cells by natural killer cells. The enhanced potency of the agalacto/asialo derivative indicates that the nature of the carbohydrate moiety exposed on the protein determines the effectiveness of the glycoprotein and its deglycosylated derivatives may function to regulate immune responses in various physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6934536      PMCID: PMC350223          DOI: 10.1073/pnas.77.10.6109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Intracellular localization of liver sugar nucleotide glycoprotein glycosyltransferases in a Golgi-rich fraction.

Authors:  H Schachter; I Jabbal; R L Hudgin; L Pinteric; E J McGuire; S Roseman
Journal:  J Biol Chem       Date:  1970-03-10       Impact factor: 5.157

2.  Regulation of T lymphocyte function by immunoregulatory alphaglobulin (IRA).

Authors:  J O Menzoian; A H Glasgow; R D Nimberg; S R Cooperband; K Schmid; I Saporoschetz; J A Mannick
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

3.  Identification of platelet orosomucoid.

Authors:  D Tripodi; J W Weis; P E Bonness; W Pollack
Journal:  Transfusion       Date:  1971 May-Jun       Impact factor: 3.157

4.  The purification and properties of beta-galactosidase from bovine testes.

Authors:  J J Distler; G W Jourdian
Journal:  J Biol Chem       Date:  1973-10-10       Impact factor: 5.157

Review 5.  Tumors and serum glycoproteins. The 'symbodies'.

Authors:  C A Apffel; J H Peters
Journal:  Prog Exp Tumor Res       Date:  1969

6.  Cell mediated immune reactions "in vitro". Reactivity of lymphocytes from animals sensitized to chicken erythrocytes, tuberculin or transplantation antigens.

Authors:  B Chapuis; K T Brunner
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

7.  The role of sialic acid in determining the survival of glycoproteins in the circulation.

Authors:  A G Morell; G Gregoriadis; I H Scheinberg; J Hickman; G Ashwell
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

8.  Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions.

Authors:  R F Mortensen; A P Osmand; H Gewurz
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

10.  Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

Authors:  R A Murgita; T B Tomasi
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Host Sialic Acids: A Delicacy for the Pathogen with Discerning Taste.

Authors:  Brandy L Haines-Menges; W Brian Whitaker; J B Lubin; E Fidelma Boyd
Journal:  Microbiol Spectr       Date:  2015-08

2.  Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.

Authors:  M J Treuheit; C E Costello; H B Halsall
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  Studies on the interaction between hyaluronan and a rat colon cancer cell line.

Authors:  C Samuelsson; S Gustafson
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

4.  Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production.

Authors:  B E Turk; H Jiang; J O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 5.  The lipocalin protein family: structure and function.

Authors:  D R Flower
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

6.  Localization and possible function of nrF-AGP, an alpha-1-acid glycoprotein-like protein in viviparous fish Neoditrema ransonnetii (Perciformes, Embiotocidae).

Authors:  Osamu Nakamura; Yuki Watabe; Naoko Matsumoto; Osamu Takasugi; Ayako Watanabe; Shigeyuki Tsutsui
Journal:  Fish Physiol Biochem       Date:  2014-11-04       Impact factor: 2.794

7.  The cytokine response element of the rat alpha 1-acid glycoprotein gene is a complex of several interacting regulatory sequences.

Authors:  K A Won; H Baumann
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

8.  Role of a SER immune suppressor in immune surveillance.

Authors:  S K Oh; S Ross; J Walker; S Zeisel
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

9.  Overexpression of alpha(1)-acid glycoprotein in transgenic mice leads to sensitisation to acute colitis.

Authors:  T Hochepied; A Wullaert; F G Berger; H Baumann; P Brouckaert; L Steidler; C Libert
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development.

Authors:  M Yiangou; C Konidaris; P Victoratos; L Hadjipetrou-Kourounakis
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.